End of draft paper.
To get the most out of your Medima P300, proper placement is non-negotiable.
: Integrates seamlessly with hospital information systems (HIS/PDMS) via MedimaNet software for remote monitoring and data management . Technical Specifications MEDIMA P300 Infusion (volumetric) pump - Med-Get
The increasing demand for rapid, accurate, and decentralized medical care has spurred the development of point-of-care (POC) devices. However, most existing systems are siloed—diagnostic devices do not communicate directly with therapeutic ones, and data integration remains a bottleneck. This paper introduces the Medima P300 , a compact, portable, multi-modal platform designed to bridge this gap. The P300 integrates (1) a 12-lead ECG and continuous vital signs monitor, (2) a laser-based flow cytometry module for complete blood counts and inflammatory markers, (3) a surface-enhanced Raman spectroscopy (SERS) chip for pathogen and biomarker identification, and (4) a microfluidic closed-loop drug delivery system. Powered by an embedded edge-AI inference engine, the device can diagnose acute coronary syndrome, sepsis, and electrolyte imbalances within 12 minutes from a single fingerstick blood sample and non-contact sensors. In therapeutic mode, the P300 administers pre-filled, algorithm-controlled medication cartridges (e.g., vasopressors, antibiotics, insulin). We present the system architecture, validation data from a pilot study (N=150), and discuss regulatory pathways. The Medima P300 represents a paradigm shift towards autonomous, interoperable POC systems for emergency rooms, ambulances, and low-resource settings.
The Medima P300 was conceived to address three persistent gaps:
End of draft paper.
To get the most out of your Medima P300, proper placement is non-negotiable.
: Integrates seamlessly with hospital information systems (HIS/PDMS) via MedimaNet software for remote monitoring and data management . Technical Specifications MEDIMA P300 Infusion (volumetric) pump - Med-Get
The increasing demand for rapid, accurate, and decentralized medical care has spurred the development of point-of-care (POC) devices. However, most existing systems are siloed—diagnostic devices do not communicate directly with therapeutic ones, and data integration remains a bottleneck. This paper introduces the Medima P300 , a compact, portable, multi-modal platform designed to bridge this gap. The P300 integrates (1) a 12-lead ECG and continuous vital signs monitor, (2) a laser-based flow cytometry module for complete blood counts and inflammatory markers, (3) a surface-enhanced Raman spectroscopy (SERS) chip for pathogen and biomarker identification, and (4) a microfluidic closed-loop drug delivery system. Powered by an embedded edge-AI inference engine, the device can diagnose acute coronary syndrome, sepsis, and electrolyte imbalances within 12 minutes from a single fingerstick blood sample and non-contact sensors. In therapeutic mode, the P300 administers pre-filled, algorithm-controlled medication cartridges (e.g., vasopressors, antibiotics, insulin). We present the system architecture, validation data from a pilot study (N=150), and discuss regulatory pathways. The Medima P300 represents a paradigm shift towards autonomous, interoperable POC systems for emergency rooms, ambulances, and low-resource settings.
The Medima P300 was conceived to address three persistent gaps: